41.59
-0.45
(-1.07%)
At close: January 31 at 4:00:02 PM EST
41.60
+0.01
+(0.02%)
After hours: 7:56:28 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-188,816.00
-260,375.00
-495,741.00
538,972.00
-238,366.00
Investing Cash Flow
-467,762.00
374,647.00
-258,655.00
-1,035,430.00
-541,170.00
Financing Cash Flow
354,047.00
62,664.00
38,592.00
250,945.00
1,016,152.00
End Cash Position
237,063.00
401,068.00
224,060.00
939,944.00
1,185,468.00
Capital Expenditure
-2,385.00
-11,970.00
-37,188.00
-81,705.00
-18,358.00
Issuance of Capital Stock
318,457.00
32,721.00
970.00
213,267.00
982,289.00
Free Cash Flow
-191,201.00
-272,345.00
-532,929.00
457,267.00
-256,724.00
12/31/2020 - 10/19/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NTLA Intellia Therapeutics, Inc.
10.32
-1.81%
BEAM Beam Therapeutics Inc.
25.92
-4.99%
EDIT Editas Medicine, Inc.
1.3100
-4.38%
VRTX Vertex Pharmaceuticals Incorporated
461.68
+5.31%
RXRX Recursion Pharmaceuticals, Inc.
7.24
-5.85%
VKTX Viking Therapeutics, Inc.
32.75
-2.79%
MRNA Moderna, Inc.
39.42
-3.95%
DNA Ginkgo Bioworks Holdings, Inc.
13.36
-3.95%
IOVA Iovance Biotherapeutics, Inc.
5.85
-5.80%
REGN Regeneron Pharmaceuticals, Inc.
672.98
-1.48%